Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon; Brian Leyland‐Jones; Steven Shak; H. Fuchs; Virginia Paton; Alex Bajamonde; Thomas Fleming; W. Eiermann; Janet Wolter; Mark D. Pegram; José Baselga; Larry Norton

Năm xuất bản2001

Nguồn học thuậtNew England Journal of Medicine

Định danhDOI 10.1056/nejm200103153441101

TRÍCH DẪN ĐỀ XUẤTAPA 7

Dennis J. Slamon; Brian Leyland‐Jones; Steven Shak; H. Fuchs; Virginia Paton; Alex Bajamonde; Thomas Fleming; W. Eiermann; Janet Wolter; Mark D. Pegram; José Baselga; Larry Norton (2001). Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2. New England Journal of Medicine, 344(11), 783-792. https://doi.org/10.1056/nejm200103153441101

Thông tin thư mục

Nguồn/Tạp chí: New England Journal of Medicine
Tập: 344
Số: 11
Trang: 783-792
Nhà xuất bản: Massachusetts Medical Society
DOI: 10.1056/nejm200103153441101 ↗

Từ khóa

Medicine; Trastuzumab; Epirubicin; Anthracycline; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Doxorubicin; Metastatic breast cancer; Paclitaxel; Cancer; Gastroenterology